Quoin Pharmaceuticals at Risk of Nasdaq Delisting Amidst Financial Challenges – TipRanks

Quoin Pharmaceuticals is facing the possibility of being delisted from the Nasdaq due to financial difficulties. The company’s struggles have put them at risk of losing their listing on the stock exchange. This news comes as a blow to Quoin Pharmaceuticals, as they work to overcome their financial challenges. Investors are closely monitoring the situation as the company works to address the issues that have led to this potential delisting. Stay tuned for updates on Quoin Pharmaceuticals and their efforts to navigate this challenging time.

Comments (0)
Add Comment